Real-World-Data on First-Line Therapy with Osimertinib in Patients with advanced EGFR-mutated NSCLC

Griesinger, F; Nieva, J; Kim, Y; Cohen, A; Horvat, P; Lu, S; Taylor, A; Yu, N; Shenolikar, R; Shaw, S

PNEUMOLOGIE, 2021; 75 (): S11